Mark Mc Cormick
About Mark Mc Cormick
Mark McCormick serves as the Head of Pricing Strategy at AXIS Re and as CEO of AXIS Re SE in Dublin, Ireland. With extensive experience in actuarial and pricing roles, he has been with AXIS Capital since 2010, holding various positions that have shaped his expertise in the field.
Work at Axis Capital
Mark McCormick currently holds two significant positions at AXIS Capital. He has served as the Head of Pricing Strategy for Axis Re since 2021. In addition, he has been the CEO of AXIS Re SE, the company's legal entity in Ireland, since 2020. His tenure at AXIS Capital has included various roles, such as Head of Pricing for Specialty Re from 2018 to 2021 and Head of Pricing for Accident & Health for a brief period in 2018. Prior to these roles, he worked as Senior Vice President Actuary - Pricing from 2014 to 2018 and Vice President Actuary - Pricing from 2010 to 2014.
Education and Expertise
Mark McCormick has a strong educational background in mathematics and actuarial science. He studied Financial and Actuarial Mathematics at Dublin City University, where he earned a Bachelor of Science degree from 1995 to 1999. He furthered his education at the Institute and Faculty of Actuaries, achieving the Fellow of the Institute of Actuaries (FIA) designation from 2002 to 2006. Additionally, he completed a Postgraduate Diploma in Computing for Commerce and Industry at The Open University in 2007.
Background
Before joining AXIS Capital, Mark McCormick worked at AmTrust Financial Services, Inc. as an Underwriter and Actuary from 2009 to 2010. His career at AXIS Capital began in 2010, and he has since progressed through various actuarial and pricing roles. His experience spans over a decade in the insurance and reinsurance sectors, focusing on pricing strategies and actuarial functions.
Achievements
Throughout his career, Mark McCormick has contributed to the development of pricing strategies within AXIS Capital. His roles have involved significant responsibilities in pricing for various lines of business, including Accident & Health and Specialty Re. His expertise in actuarial science and pricing has been instrumental in shaping the company's approach to risk assessment and financial management.